Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADK | P55263 | 3/20 | 0.60 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.52 |
| ▸ | METTL3 | Q86U44 | 2/20 | 0.50 |
| ▸ | METTL14 | Q9HCE5 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31167393 | 1.00 | ADK (0.60) | ADKSLC29A1METTL3METTL14 | |
| SCHEMBL27103047 | 0.92 | ADK (0.50) | ADKSLC29A1METTL3METTL14 | |
| SCHEMBL24687181 | 0.92 | ADK (0.72) | ADKSLC29A1METTL3METTL14 | |
| SCHEMBL23023836 | 0.92 | ADK (0.72) | ADKSLC29A1METTL3METTL14 | |
| SCHEMBL31123791 | 0.92 | ADK (0.72) | ADKSLC29A1METTL3METTL14 | |
| SCHEMBL23621389 | 0.85 | LMNA (0.60) | SLC29A1 | |
| SCHEMBL18521420 | 0.85 | LMNA (0.60) | SLC29A1 | |
| SCHEMBL21625242 | 0.85 | LMNA (0.60) | SLC29A1 | |
| SCHEMBL21063207 | 0.85 | LMNA (0.60) | SLC29A1 | |
| SCHEMBL314052 | 0.85 | LMNA (0.60) | SLC29A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4489792-A1 | PHENYL MALEIMIDE LINKER AGENTS | Firefly Bio, Inc. (US) | 2025-01-15 | — | — | EP | disclosed |
| US-20240067640-A1 | PHENYL MALEIMIDE LINKER AGENTS | FIREFLY BIO, INC. | 2024-02-29 | — | — | US | disclosed |
| US-20240067640-A1 | PHENYL MALEIMIDE LINKER AGENTS | FIREFLY BIO, INC. | 2024-02-29 | — | — | US | disclosed |
| WO-2023173121-A1 | PHENYL MALEIMIDE LINKER AGENTS | FIREFLY BIO, INC. (US) | 2023-09-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240067640-A1 | PHENYL MALEIMIDE LINKER AGENTS | TPX2, H1-4, MAPT | ADK 3941/4885SLC29A1 268/4885METTL3 2305/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.